Form 4: Bristol-Myers Squibb Director Peter J. Arduini Reports Acquisition of Deferred Share Units

Director Peter J. Arduini reports acquisition of deferred share units convertible to common stock in a recent transaction.

Summary

• On March 31, 2024, Peter J. Arduini, a director of Bristol-Myers Squibb, acquired 645.399 deferred share units.
• These units are convertible into shares of common stock upon settlement, which occurs when Arduini ceases to be a director or at a previously specified future date.
• The price per unit was $54.23.
• Following the transaction, Arduini beneficially owns 52,708.649 deferred share units, which includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard Form 4 filing indicating a director's acquisition of deferred share units. It doesn't inherently suggest positive or negative implications.

Positives

• The acquisition of deferred share units by a director signals confidence in the company's future performance.

Future Outlook

The deferred share units will be converted into common stock upon settlement, which will occur when the reporting person ceases to be a director or at a future date previously specified by the reporting person.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge sentiment and potential future actions of key personnel.

Stakeholder Impact

• The acquisition of deferred share units by a director can be viewed positively by shareholders as it aligns the director's interests with the company's long-term success.

Key Dates